Biohaven Busy Work


I really like this company so much. So far they’ve treated us like gold IMO. I really hope they hang in there with all of us until we get out in the field when all of this is over. I was impressed with our numbers out of the gate, but the potential is there to do so much more once CV is put to rest. My offices own say their patient load is down more than half, offices have laid off much of their staff, docs are being called out of their office to work urgent care, and many hospitals won’t let delivery people in to deliver meals- so little chance of a virtual lunch. This drug is going to change the market. I hope the company can hang in there with all of us, until CV is over and all gets back to somewhat of a normal place. If they do, we are going to be hard to stop

“This drug is going to change the market” Seriously? Every single company that comes out with some pricey new drug says this. “Oh, it’s a game changer!!” and “This drug is going to change the treatment of XYZ disease state!!” You need to put down the Kool Aid and get real. It’s not going to change anything. Docs will keep reaching for generics because that’s what they are being told to do by managed care. Managed Care controls everything. It’s all about the bottom line. I don’t know what the future holds for the pharma industry. We need the innovation they bring to the treatment of disease. But it’s useless if doctors won’t write the drugs because they are expensive, require PA’s, and they get penalized by managed care for writing branded drugs.
 
“This drug is going to change the market” Seriously? Every single company that comes out with some pricey new drug says this. “Oh, it’s a game changer!!” and “This drug is going to change the treatment of XYZ disease state!!” You need to put down the Kool Aid and get real. It’s not going to change anything. Docs will keep reaching for generics because that’s what they are being told to do by managed care. Managed Care controls everything. It’s all about the bottom line. I don’t know what the future holds for the pharma industry. We need the innovation they bring to the treatment of disease. But it’s useless if doctors won’t write the drugs because they are expensive, require PA’s, and they get penalized by managed care for writing branded drugs.
You make too much sense. If a company cannot get their drug onto large formularies at a reasonable price then sorry- not a good formula for success.
 
The new model is to give away the product for 6-9 months to drive clinical experience for providers and patients. Company can then license use to managed care companies.
 
There are more drugs in the pipeline.


Yeah a lot of us came on board with this golden carrot dangled in front of us, but reality has now set in, and we realize that any approvals are a couple of years down the road. Plus no bipolar drug. Then the pandemic hit the week of launch, plus they’re giving away a huge portion of scripts with savings card. I don’t know how this company can sustain all of these reps. Don’t misunderstand me, I hope they can. But I really don’t know how it’s possible
 
Yeah a lot of us came on board with this golden carrot dangled in front of us, but reality has now set in, and we realize that any approvals are a couple of years down the road. Plus no bipolar drug. Then the pandemic hit the week of launch, plus they’re giving away a huge portion of scripts with savings card. I don’t know how this company can sustain all of these reps. Don’t misunderstand me, I hope they can. But I really don’t know how it’s possible

look at it this way, we are carrying a $125-$145 Million field force cost.

unless this drug does $1 billion, no CFO is going to let that slide for too long.
 
look at it this way, we are carrying a $125-$145 Million field force cost.

unless this drug does $1 billion, no CFO is going to let that slide for too long.

There’s no reason to think we can’t eventually got to a billion with Nurtec. If each territory averages 200 patients per year on drug at a AWP of $850 per month, that’s $2 million per territory. If we have 300 territories, that’s $600 million. I’m not saying we get there this year, but it’s totally doable.
 
There’s no reason to think we can’t eventually got to a billion with Nurtec. If each territory averages 200 patients per year on drug at a AWP of $850 per month, that’s $2 million per territory. If we have 300 territories, that’s $600 million. I’m not saying we get there this year, but it’s totally doable.
That's a high AWP for this product
 
There’s no reason to think we can’t eventually got to a billion with Nurtec. If each territory averages 200 patients per year on drug at a AWP of $850 per month, that’s $2 million per territory. If we have 300 territories, that’s $600 million. I’m not saying we get there this year, but it’s totally doable.

OK, now throw in rebates of 40-50% to get any kind of payer coverage and you can cut your revenue in half.

Not many migraine drugs out there that hit $1 billion.
 
There’s no reason to think we can’t eventually got to a billion with Nurtec. If each territory averages 200 patients per year on drug at a AWP of $850 per month, that’s $2 million per territory. If we have 300 territories, that’s $600 million. I’m not saying we get there this year, but it’s totally doable.
How many Rxs are territories averaging?
 


Write your reply...